Literature DB >> 19770411

Cardiovascular effects of noncardiovascular drugs.

Satish R Raj1, C Michael Stein, Pablo J Saavedra, Dan M Roden.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19770411      PMCID： PMC2773827          DOI： 10.1161/CIRCULATIONAHA.107.728576

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  120 in total

Review 1.  Carcinoid heart disease.

Authors:  Sanjeev Bhattacharyya; Joseph Davar; Gilles Dreyfus; Martyn E Caplin
Journal:  Circulation       Date:  2007-12-11       Impact factor: 29.690

2.  Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.

Authors:  S Nattel; S Ranger; M Talajic; R Lemery; D Roy
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

Review 3.  ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

Authors:  M D Cheitlin; A M Hutter; R G Brindis; P Ganz; S Kaul; R O Russell; R M Zusman
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

4.  Corticosteroids and the risk of atrial fibrillation.

Authors:  Cornelis S van der Hooft; Jan Heeringa; Guy G Brusselle; Albert Hofman; Jacqueline C M Witteman; J Herre Kingma; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Arch Intern Med       Date:  2006-05-08

Review 5.  Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies.

Authors:  E Garbe; S Suissa
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

6.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

7.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

Review 8.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.

Authors:  Patrick Mbaya; Faouzi Alam; Sindhu Ashim; David Bennett
Journal:  Hum Psychopharmacol       Date:  2007-04       Impact factor: 1.672

Review 10.  Alpha1-adrenergic blockers: current usage considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-12       Impact factor: 3.738
View more
  2 in total

1.  Illuminating drug action by network integration of disease genes: a case study of myocardial infarction.

Authors:  Rui-Sheng Wang; Joseph Loscalzo
Journal:  Mol Biosyst       Date:  2016-04-26

Review 2.  The Risk of Fatal Arrhythmias in Post-Myocardial Infarction Depression in Association With Venlafaxine.

Authors:  Sai Dheeraj Gutlapalli; Vamsi Krishna Lavu; Rana Abdelwahab Mohamed; Ruimin Huang; Shanthi Potla; Sushen Bhalla; Yousif Al Qabandi; Savitri Aninditha Nandula; Chinmayi Sree Boddepalli; Pousette Hamid
Journal:  Cureus       Date:  2022-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.